Imunon, Inc. Retained Earnings
Imunon, Inc. (IMNN) had Retained Earnings of -$428.36 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$428.36M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$425.55M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$421.30M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$417.08M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$428.36M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$425.55M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$421.30M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$417.08M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$413.65M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | -$410.91M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$406.80M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$402.75M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$397.90M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$393.11M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$388.18M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$383.29M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$379.82M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$374.26M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$368.67M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$355.44M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$349.29M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$343.24M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$332.77M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$328.55M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$323.14M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$317.69M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$312.00M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$308.99M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$300.92M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$295.57M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$290.52M 10-K · filed 2021-03-19 | |
| 2019-09-30 | -$287.41M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$281.94M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$276.03M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$273.67M 10-K · filed 2020-03-25 | |
| 2018-09-30 | -$279.15M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$274.49M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$266.26M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | -$261.78M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$257.10M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$251.43M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$246.54M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$241.38M 10-K · filed 2018-03-27 | |
| 2016-09-30 | -$235.67M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$228.76M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$224.02M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$218.13M 10-K · filed 2017-03-24 | |
| 2015-09-30 | -$212.49M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$208.07M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$202.25M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$195.07M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$188.50M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$181.51M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$174.74M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$169.29M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$165.30M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$155.70M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$156.12M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$156.26M 10-K · filed 2014-03-13 | -$150.88M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$142.62M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$136.60M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$130.47M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$124.22M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$118.09M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$111.67M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$100.94M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |